Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), 60 microgram HA/stam clinical trials

A Phase 1/2, randomized, dose-finding/dose-confirmation study to evaluate the reactogenicity, safety and immunogenicity of mRNA-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults

This study is testing new mRNA flu vaccines in healthy adults. Researchers want to see how safe they are, if they cause side effects, and how well they help your body fight the flu, compared to existing flu jabs. It's a key first step for new vaccine development.